I see a 5 waves move up finished at $61 on 20th December, fallowed by an A-B-C standard correction. Using the guideline of equality A=C and the Trend Based Fibonacci extension Pfizer will drop till about 1 level or $41. This has support as well from $41 OCT 2021 level which is also the W4 level in the previous impulse movement. Disclaimer: This is my analysis...
$MRNA is currently running trials on an HIV vaccine. Why? Because they, as well $PFE, with the vaccines and the booster programs have now decimated people's immune systems. $PFE at least has other products on the market, they may ultimately survive, but this could be the end of $MRNA. People are dying of Vaccine induced AIDS. The media and world leaders (lead...
on weekly we can see bearish divergence on RSI. there is also possible h&s forming. we have also fundemantals about rigged vaccine trials for emergency authorization acceptance, vaccine deaths piling up and big shareholders of Pfizer dumping their stock. sell now! first profit target 32$ second profit target 1$
Pfizer - Short Term - We look to Sell at 49.33 (stop at 51.54) The trend of lower highs is located at 53.50. Previous support located at 50.00. A move through bespoke support at 50.00 and we look for extended losses. Closed below the 20-day EMA. The medium term bias remains bearish. Our profit targets will be 43.51 and 41.00 Resistance: 54.00 / 57.00 /...
-The reason why PFE is dropping is not the economical situation but rather the COVID situation which is getting lighter (at least in folk's mind) every day. -We got omicron but it being a light virus almost like a flu also didn't catch much attention lately. -This stock throughout the pandemic depended on negative news, whoever is chaos oriented invested in this...
I got an alert on Pfizer NYSE:PFE just now that on the 30m a Tradingview Spike Alert I had setup fired. This is following research I did over the weekend to the Support level that PFE reached in the recent down move. While doing that I found an old annotation from November 2020 earnings that informed a long term dividend investment play. It's nice to see how...
NYSE:PFE A hammer signaled reversal for $PFE. Shortly after price broke out of the downtrend resistance. Four inside bars have formed during period of consolidation. $PFE looks primed for sharp movement. Catalyst would likely be FDA / CDC approval/rejection of its Covid vaccination for children, expected in 4th week of Feb. Application is for 2 doses,...
Historically, Pfizer has not had much momentum when it comes to stock performance. Over the past ten years, the S&P 500 Index has outperformed this large pharmaceutical company. But now Pfizer is gaining momentum. Last year it outperformed the benchmark index - Pfizer was up 60%, while the S&P 500 was up 27%. And today's Pfizer doesn't look much like Pfizer did a...
Hello friends, Black Mountain Analysis Team: PFIZER price after a good climb to the top is resting - Time resting or price resting - You can see the positive divergence of the RSI indicator in the chart. If supported, we can expect to climb again in the new year. TP1=61-62$ TP2=65$ TP3=70-74$ ____________________________ sl=54$
You can buy Pfizer ( PFE ) target 61.87 stop loss 53.5 Money management your responsibility. I recommend entering a maximum of 10% of the portfolio. Good luck
Fundamental Analysis Pfizer, Inc. has consistently been one of the largest pharmaceutical companies in the world for the better part of the last two decades. The company has a remarkable history going back all the way to the year 1849, when Pfizer was founded in Brooklyn, New York. The large cap pharma giant has developed a well-balanced and deep portfolio of...
Bull flag in the trading sense of the word... I could see a retest of the ATH...Pretty sure the shareholders can too. Bull flag within the ascending broadening wedge pattern may visit around the $55.00 region first. Look at how fast this ones moved though. No surprises eh. Personally not trading this instrument.
Pharmaceutical giant Pfizer has been at the forefront of the industry, developing drugs to treat COVID since the pandemic began. Unfortunately, the world continues to struggle with different strains of the virus, most recently with the Omicron variant, but Pfizer's products are still in high demand, which will likely boost its results in 2022. It's been about a...
Black Mountain Analytical Team in the previous Pfizer Idea update: We see that the resistance line of the rsi indicator is broken in the monthly time frame, if the failure is not fake and has happened validly, we can expect good things from this company. There is also a pulse of positive news from the company. (Pfizer and BioNTech Provide on Omicron Variant)
Pfizer Pfizer Pfizer where do i start? over the past month Pfizer has been on an uptrend. good news bad news omicron covid etc. this thing just keeps going and i do not think it’s done. i have been scalping this over the past two weeks and on Friday we closed on an inside bar on the 30-minute window which we can see is a period of consolidation. i think Pfizer...
Pfizer going over 100 easily why it hasn't yet ? Idk but it should be.
PFE is overrated and pumped by the media and those with agendas. I am expecting PFE to pullback to Target 1 55.66 - 55.47 and possibly down to Target 2 of 52.85 - 56.60.
There is so much baked into the markets with vaccines. I expect PFE to have some downside to 55.66 to 55.47 as a T1 downside Target.